BioNeMo
NVIDIA and Novo Nordisk Partner to Accelerate AI-Driven Drug Discovery
NVIDIA; Novo Nordisk; AI models; drug discovery; Gefion AI Supercomputer; BioNeMo; Omniverse; pharmaceutical innovation
ReSync Bio, Sapio Sciences adopt Nvidia BioNeMo to supercharge AI drug discovery
Drug Discovery, Aortic Valve Insufficiency, Sapio, Sapio Sciences, Bio, NVIDIA ‘s, BioNeMo, microservices